Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-07-13

Clinical Trial Update: Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain [NA]

View source ↗

Summary

The clinical trial assessing the endogenous opioid system's role in modulating experimental pain in temporomandibular disorder and facial pain has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Temporomandibular Disorder, Facial Pain | NA | Status: WITHDRAWN